Our recent study on combination differentiation therapy for medulloblastoma has been accepted for publication in Molecular Therapy Oncology. This work further supports our upcoming clinical trial evaluating T3 treatment in medulloblastoma patients: ClinicalTrials.gov NCT07346157

Congratulations to all authors and collaborators involved in this work.